Gravar-mail: ATNT-13 A PHASE I DOSE ESCALATION AND CENTRAL NERVOUS SYSTEM (CNS) PHARMACOKINETIC STUDY OF DEXANABINOL IN PATIENTS WITH BRAIN CANCER